<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02735122</url>
  </required_header>
  <id_info>
    <org_study_id>CO-151027203834-PACT</org_study_id>
    <nct_id>NCT02735122</nct_id>
  </id_info>
  <brief_title>Study of Acetaminophen (ACM) in Post-operative Dental Pain</brief_title>
  <official_title>A Randomized, Double-Blind, Placebo- and Active- Controlled, Single-Dose, Efficacy, Safety, and Pharmacokinetics Study of a Test Acetaminophen 500 mg Tablet in Postoperative Dental Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johnson &amp; Johnson Consumer Inc., McNeil Consumer Healthcare Division</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Johnson &amp; Johnson Consumer and Personal Products Worldwide</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Johnson &amp; Johnson Consumer and Personal Products Worldwide</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a Dental Pain Study which will evaluate the analgesic onset, efficacy and safety of
      1000 mg acetaminophen as two Test acetaminophen 500 mg tablets, compared with commercial
      products of acetaminophen 1000 mg administered as two 500 mg caplets, and ibuprofen (IBU) 400
      mg following third molar (wisdom tooth) extraction.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a single-dose, randomized, double-blind, triple-dummy, placebo- and active
      controlled, parallel-group study to evaluate the analgesic onset, efficacy, and safety
      profile of Test acetaminophen 1000 mg compared with two commercial products over a six-hour
      period after third-molar extractions. Subjects will undergo dental extraction of three or
      four third molars.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 30, 2016</start_date>
  <completion_date type="Actual">October 5, 2016</completion_date>
  <primary_completion_date type="Actual">October 5, 2016</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to first confirmed perceptible pain relief</measure>
    <time_frame>6 hours</time_frame>
    <description>Minutes until confirmed first perceptible pain relief are achieved. Stopwatch is started after the subject takes the study medication. The subject is instructed to stop the stopwatch when they first begin to feel any pain relief. The first perceptible pain relief is confirmed if the subject also stopped the second stopwatch indicating meaningful pain relief.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of subjects with confirmed perceptible relief from 30 minutes to successively earlier minutes in one-minute increments (Test ACM versus placebo)</measure>
    <time_frame>30 minutes or less</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Risk ratios of confirmed perceptible relief by 10 minutes (Test acetominophen and commercial ibuprofen)</measure>
    <time_frame>10 minutes or less</time_frame>
    <description>The risk ratios and confidence intervals for incidence of confirmed perceptible relief of Test ACM divided by commercial IBU will be presented for 10 minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Risk ratios of confirmed perceptible relief by 15 minutes (Test acetominophen and commercial ibuprofen)</measure>
    <time_frame>15 minutes or less</time_frame>
    <description>The risk ratios and confidence intervals for incidence of confirmed perceptible relief of Test ACM divided by commercial IBU will be presented for 15 minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Risk ratios of confirmed perceptible relief by 20 minutes (Test acetominophen and commercial ibuprofen)</measure>
    <time_frame>20 minutes or less</time_frame>
    <description>The risk ratios and confidence intervals for incidence of confirmed perceptible relief of Test ACM divided by commercial IBU will be presented for 20 minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of subjects with meaningful relief by 30 minutes</measure>
    <time_frame>30 minutes or less</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to meaningful pain relief</measure>
    <time_frame>6 hours</time_frame>
    <description>Minutes until meaningful pain relief are achieved. Stopwatch is started after the subject takes the study medication. The subjects are instructed to stop the stopwatch when the relief from the starting pain is meaningful to them.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">420</enrollment>
  <condition>Post Operative Dental Pain</condition>
  <arm_group>
    <arm_group_label>Test acetaminophen</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>acetaminophen tablet and placebo caplet and placebo liquid-filled capsule</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Commercial acetaminophen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>acetaminophen caplet and placebo tablet and placebo liquid-filled capsule</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Commercial ibuprofen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>ibuprofen liquid-filled capsule and placebo tablet and placebo caplet</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo tablet and placebo caplet and placebo liquid-filled capsule</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>acetaminophen Tablet</intervention_name>
    <description>2 test acetaminophen 500 mg tablets</description>
    <arm_group_label>Test acetaminophen</arm_group_label>
    <other_name>Test ACM</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>acetaminophen Caplet</intervention_name>
    <description>2 commercial acetaminophen 500 mg caplets</description>
    <arm_group_label>Commercial acetaminophen</arm_group_label>
    <other_name>Commercial ACM</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ibuprofen Liquid-filled capsule</intervention_name>
    <description>2 commercial ibuprofen 200 mg Liquid-filled capsules</description>
    <arm_group_label>Commercial ibuprofen</arm_group_label>
    <other_name>Commercial IBU</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo Tablet</intervention_name>
    <description>2 placebo tablets</description>
    <arm_group_label>Commercial acetaminophen</arm_group_label>
    <arm_group_label>Commercial ibuprofen</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo Caplet</intervention_name>
    <description>2 placebo caplets</description>
    <arm_group_label>Test acetaminophen</arm_group_label>
    <arm_group_label>Commercial ibuprofen</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo Liquid-filled capsule</intervention_name>
    <description>2 placebo Liquid-filled capsules</description>
    <arm_group_label>Test acetaminophen</arm_group_label>
    <arm_group_label>Commercial acetaminophen</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. 17 years to 50 years old

          2. Weight 100 lbs or greater with a body mass index (BMI) 18-30 inclusive

          3. Dental extraction of three or four molars

          4. Experience moderate to severe pain after extraction of third molars

          5. Females of childbearing age must be willing to use acceptable method of birth control

        Exclusion Criteria:

          1. Currently pregnant or planning to be pregnant or nursing a baby

          2. Known allergy to acetaminophen (ACM) or non-steroidal anti-inflammatory drugs (NSAIDS)

          3. Inability to swallow whole large tablets or capsules

          4. Have other conditions that the investigator feels may impact subject's safety and/or
             the integrity of the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>17 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Derek D. Muse, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Jean Brown Research</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Jean Brown Research</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84124</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 31, 2016</study_first_submitted>
  <study_first_submitted_qc>April 6, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 12, 2016</study_first_posted>
  <disposition_first_submitted>October 9, 2017</disposition_first_submitted>
  <disposition_first_submitted_qc>December 15, 2017</disposition_first_submitted_qc>
  <disposition_first_posted type="Actual">December 18, 2017</disposition_first_posted>
  <last_update_submitted>December 15, 2017</last_update_submitted>
  <last_update_submitted_qc>December 15, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 18, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Toothache</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Ibuprofen</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>At this time we do plan to share IPD through the YODA site. The specific individual participant data sets have not yet been determined.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted, but a results disposition has been submitted           -->
</clinical_study>

